% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • tippy_09137 tippy_09137 Apr 25, 2014 9:32 AM Flag

    OT: CYTK getting slammed....

    April 25 (Reuters) - Cytokinetics Inc said its experimental treatment for Lou Gehrig's disease - a progressive neurodegenerative disorder - failed the main goal in a mid-stage trial.

    The study tested the efficacy of the drug, tirasemtiv - one of the company's lead compounds - against a placebo in 711 patients with amyotrophic lateral sclerosis (ALS).

    The San Francisco-based company's stock was halted before the bell on Friday.

11.34+0.14(+1.25%)May 23 4:00 PMEDT